FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:KDM2A-SYNDIG1

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: KDM2A-SYNDIG1
FusionPDB ID: 41738
FusionGDB2.0 ID: 41738
HgeneTgene
Gene symbol

KDM2A

SYNDIG1

Gene ID

22992

79953

Gene namelysine demethylase 2Asynapse differentiation inducing 1
SynonymsCXXC8|FBL11|FBL7|FBXL11|JHDM1A|LILINAC20orf39|DSPC2|IFITMD5|TMEM90B
Cytomap

11q13.2

20p11.21

Type of geneprotein-codingprotein-coding
Descriptionlysine-specific demethylase 2ACXXC-type zinc finger protein 8F-box and leucine-rich repeat protein 11F-box/LRR-repeat protein 11[Histone-H3]-lysine-36 demethylase 1AjmjC domain-containing histone demethylation protein 1Ajumonji C domain-containing hsynapse differentiation-inducing gene protein 1dispanin subfamily C member 2interferon induced transmembrane protein domain containing 5synapse differentiation induced gene 1transmembrane protein 90B
Modification date2020032020200313
UniProtAcc

Q9Y2K7

Main function of 5'-partner protein: FUNCTION: Histone demethylase that specifically demethylates 'Lys-36' of histone H3, thereby playing a central role in histone code. Preferentially demethylates dimethylated H3 'Lys-36' residue while it has weak or no activity for mono- and tri-methylated H3 'Lys-36'. May also recognize and bind to some phosphorylated proteins and promote their ubiquitination and degradation. Required to maintain the heterochromatic state. Associates with centromeres and represses transcription of small non-coding RNAs that are encoded by the clusters of satellite repeats at the centromere. Required to sustain centromeric integrity and genomic stability, particularly during mitosis. Regulates circadian gene expression by repressing the transcriptional activator activity of CLOCK-ARNTL/BMAL1 heterodimer and RORA in a catalytically-independent manner (PubMed:26037310). {ECO:0000269|PubMed:16362057, ECO:0000269|PubMed:19001877, ECO:0000269|PubMed:26037310, ECO:0000269|PubMed:28262558}.
.
Ensembl transtripts involved in fusion geneENST idsENST00000526258, ENST00000398645, 
ENST00000529006, ENST00000308783, 
ENST00000530342, 
ENST00000376862, 
ENST00000482637, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score36 X 24 X 17=146884 X 5 X 3=60
# samples 505
** MAII scorelog2(50/14688*10)=-4.87656605875172
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(5/60*10)=-0.263034405833794
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: KDM2A [Title/Abstract] AND SYNDIG1 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: KDM2A [Title/Abstract] AND SYNDIG1 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)KDM2A(66999431)-SYNDIG1(24565492), # samples:2
Anticipated loss of major functional domain due to fusion event.KDM2A-SYNDIG1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
KDM2A-SYNDIG1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
KDM2A-SYNDIG1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
KDM2A-SYNDIG1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
TgeneSYNDIG1

GO:0051965

positive regulation of synapse assembly

20152115



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr11:66999431/chr20:24565492)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across KDM2A (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across SYNDIG1 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000398645KDM2Achr1166999431+ENST00000376862SYNDIG1chr2024565492+375223438642639591
ENST00000529006KDM2Achr1166999431+ENST00000376862SYNDIG1chr2024565492+333419254462221591
ENST00000398645KDM2Achr1166999431+ENST00000376862SYNDIG1chr2024565491+375223438642639591
ENST00000529006KDM2Achr1166999431+ENST00000376862SYNDIG1chr2024565491+333419254462221591

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000398645ENST00000376862KDM2Achr1166999431+SYNDIG1chr2024565492+0.0029157080.9970843
ENST00000529006ENST00000376862KDM2Achr1166999431+SYNDIG1chr2024565492+0.0026512210.9973488
ENST00000398645ENST00000376862KDM2Achr1166999431+SYNDIG1chr2024565491+0.0029157080.9970843
ENST00000529006ENST00000376862KDM2Achr1166999431+SYNDIG1chr2024565491+0.0026512210.9973488

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for KDM2A-SYNDIG1

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
KDM2Achr1166999431SYNDIG1chr20245654911925493GIEDEDALIADVKSDYSSDTESEDNF
KDM2Achr1166999431SYNDIG1chr20245654912343493GIEDEDALIADVKSDYSSDTESEDNF
KDM2Achr1166999431SYNDIG1chr20245654921925493GIEDEDALIADVKSDYSSDTESEDNF
KDM2Achr1166999431SYNDIG1chr20245654922343493GIEDEDALIADVKSDYSSDTESEDNF

Top

Potential FusionNeoAntigen Information of KDM2A-SYNDIG1 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
KDM2A-SYNDIG1_66999431_24565491.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
KDM2A-SYNDIG1chr1166999431chr20245654912343HLA-B15:01LIADVKSDY0.99910.637716
KDM2A-SYNDIG1chr1166999431chr20245654912343HLA-B15:25LIADVKSDY0.99540.6755716
KDM2A-SYNDIG1chr1166999431chr20245654912343HLA-B15:02LIADVKSDY0.98940.6832716
KDM2A-SYNDIG1chr1166999431chr20245654912343HLA-B15:01ALIADVKSDY0.99960.6462616
KDM2A-SYNDIG1chr1166999431chr20245654912343HLA-B15:25ALIADVKSDY0.99020.7135616
KDM2A-SYNDIG1chr1166999431chr20245654912343HLA-B15:05LIADVKSDY0.96860.5681716
KDM2A-SYNDIG1chr1166999431chr20245654912343HLA-B15:31LIADVKSDY0.94840.5675716
KDM2A-SYNDIG1chr1166999431chr20245654912343HLA-B15:04ALIADVKSDY0.98080.6688616
KDM2A-SYNDIG1chr1166999431chr20245654912343HLA-B15:05ALIADVKSDY0.93910.6579616
KDM2A-SYNDIG1chr1166999431chr20245654912343HLA-B15:34LIADVKSDY0.99910.637716
KDM2A-SYNDIG1chr1166999431chr20245654912343HLA-B15:125LIADVKSDY0.99910.637716
KDM2A-SYNDIG1chr1166999431chr20245654912343HLA-B15:27LIADVKSDY0.99910.6952716
KDM2A-SYNDIG1chr1166999431chr20245654912343HLA-B15:33LIADVKSDY0.99910.637716
KDM2A-SYNDIG1chr1166999431chr20245654912343HLA-B15:135LIADVKSDY0.99910.647716
KDM2A-SYNDIG1chr1166999431chr20245654912343HLA-B15:50LIADVKSDY0.99890.6519716
KDM2A-SYNDIG1chr1166999431chr20245654912343HLA-B15:11LIADVKSDY0.99830.5351716
KDM2A-SYNDIG1chr1166999431chr20245654912343HLA-B15:08LIADVKSDY0.9980.5353716
KDM2A-SYNDIG1chr1166999431chr20245654912343HLA-B15:12LIADVKSDY0.99740.5949716
KDM2A-SYNDIG1chr1166999431chr20245654912343HLA-B35:43LIADVKSDY0.99730.5301716
KDM2A-SYNDIG1chr1166999431chr20245654912343HLA-B15:39LIADVKSDY0.99520.5058716
KDM2A-SYNDIG1chr1166999431chr20245654912343HLA-B15:35LIADVKSDY0.9950.6018716
KDM2A-SYNDIG1chr1166999431chr20245654912343HLA-B35:11LIADVKSDY0.98750.6421716
KDM2A-SYNDIG1chr1166999431chr20245654912343HLA-B15:20LIADVKSDY0.97160.6846716
KDM2A-SYNDIG1chr1166999431chr20245654912343HLA-B15:125ALIADVKSDY0.99960.6462616
KDM2A-SYNDIG1chr1166999431chr20245654912343HLA-B15:34ALIADVKSDY0.99960.6462616
KDM2A-SYNDIG1chr1166999431chr20245654912343HLA-B15:33ALIADVKSDY0.99960.6462616
KDM2A-SYNDIG1chr1166999431chr20245654912343HLA-B15:27ALIADVKSDY0.99950.6856616
KDM2A-SYNDIG1chr1166999431chr20245654912343HLA-B15:135ALIADVKSDY0.99950.65616
KDM2A-SYNDIG1chr1166999431chr20245654912343HLA-B15:50ALIADVKSDY0.99940.7475616
KDM2A-SYNDIG1chr1166999431chr20245654912343HLA-B15:12ALIADVKSDY0.99870.5764616
KDM2A-SYNDIG1chr1166999431chr20245654912343HLA-B15:35ALIADVKSDY0.99860.6244616
KDM2A-SYNDIG1chr1166999431chr20245654912343HLA-B15:39ALIADVKSDY0.99050.5654616
KDM2A-SYNDIG1chr1166999431chr20245654912343HLA-B15:20ALIADVKSDY0.94140.7329616

Top

Potential FusionNeoAntigen Information of KDM2A-SYNDIG1 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
KDM2A-SYNDIG1_66999431_24565491.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0301EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0301DEDALIADVKSDYSS318
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0301EDEDALIADVKSDYS217
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0301DALIADVKSDYSSDT520
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0303EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0303DEDALIADVKSDYSS318
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0303DALIADVKSDYSSDT520
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0303EDEDALIADVKSDYS217
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0305EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0305DEDALIADVKSDYSS318
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0305EDEDALIADVKSDYS217
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0305DALIADVKSDYSSDT520
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0307EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0307DEDALIADVKSDYSS318
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0307DALIADVKSDYSSDT520
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0307EDEDALIADVKSDYS217
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0310EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0310DEDALIADVKSDYSS318
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0310EDEDALIADVKSDYS217
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0310DALIADVKSDYSSDT520
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0310IEDEDALIADVKSDY116
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0313EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0313DEDALIADVKSDYSS318
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0313EDEDALIADVKSDYS217
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0313DALIADVKSDYSSDT520
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0315EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0315DEDALIADVKSDYSS318
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0315EDEDALIADVKSDYS217
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0315DALIADVKSDYSSDT520
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0318EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0318DEDALIADVKSDYSS318
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0318EDEDALIADVKSDYS217
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0318DALIADVKSDYSSDT520
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0320EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0320DEDALIADVKSDYSS318
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0320EDEDALIADVKSDYS217
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0320DALIADVKSDYSSDT520
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0322EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0322DEDALIADVKSDYSS318
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0322EDEDALIADVKSDYS217
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0322DALIADVKSDYSSDT520
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0324EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0324DEDALIADVKSDYSS318
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0324EDEDALIADVKSDYS217
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0324DALIADVKSDYSSDT520
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0326EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0326DEDALIADVKSDYSS318
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0326EDEDALIADVKSDYS217
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0326DALIADVKSDYSSDT520
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0328EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0328DEDALIADVKSDYSS318
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0328EDEDALIADVKSDYS217
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0328DALIADVKSDYSSDT520
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0330EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0330DEDALIADVKSDYSS318
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0330EDEDALIADVKSDYS217
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0330DALIADVKSDYSSDT520
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0332EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0332DEDALIADVKSDYSS318
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0332EDEDALIADVKSDYS217
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0332DALIADVKSDYSSDT520
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0334EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0334DEDALIADVKSDYSS318
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0334EDEDALIADVKSDYS217
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0334DALIADVKSDYSSDT520
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0336EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0336DEDALIADVKSDYSS318
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0336EDEDALIADVKSDYS217
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0336DALIADVKSDYSSDT520
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0338EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0338DEDALIADVKSDYSS318
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0340EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0340DEDALIADVKSDYSS318
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0340EDEDALIADVKSDYS217
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0340DALIADVKSDYSSDT520
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0342EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0342DEDALIADVKSDYSS318
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0342EDEDALIADVKSDYS217
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0342DALIADVKSDYSSDT520
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0344EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0344DEDALIADVKSDYSS318
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0344EDEDALIADVKSDYS217
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0344DALIADVKSDYSSDT520
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0346EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0346DEDALIADVKSDYSS318
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0346EDEDALIADVKSDYS217
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0346DALIADVKSDYSSDT520
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0348EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0348DEDALIADVKSDYSS318
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0348EDEDALIADVKSDYS217
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0348DALIADVKSDYSSDT520
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0350EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0350DEDALIADVKSDYSS318
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0350EDEDALIADVKSDYS217
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0350DALIADVKSDYSSDT520
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0352EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0352DEDALIADVKSDYSS318
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0352EDEDALIADVKSDYS217
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0352DALIADVKSDYSSDT520
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0354EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0354DEDALIADVKSDYSS318
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0354EDEDALIADVKSDYS217
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0354DALIADVKSDYSSDT520
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-0470DALIADVKSDYSSDT520
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-1107EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-1107DEDALIADVKSDYSS318
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-1107DALIADVKSDYSSDT520
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-1107EDEDALIADVKSDYS217
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-1179EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-1179DEDALIADVKSDYSS318
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-1333EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-1381EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-1394EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-1394DEDALIADVKSDYSS318
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-1419EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-1421EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-1421DEDALIADVKSDYSS318
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-1433EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-1476EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-1476DEDALIADVKSDYSS318
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-1476EDEDALIADVKSDYS217
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-1476DALIADVKSDYSSDT520
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-1479EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-1479DEDALIADVKSDYSS318
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-1479EDEDALIADVKSDYS217
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-1479DALIADVKSDYSSDT520
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-1480EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-1482EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-1495EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB1-1495DEDALIADVKSDYSS318
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB3-0114EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB3-0114DEDALIADVKSDYSS318
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB3-0114EDEDALIADVKSDYS217
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB4-0101DALIADVKSDYSSDT520
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB4-0101EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB4-0103DALIADVKSDYSSDT520
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB4-0103EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB4-0106DALIADVKSDYSSDT520
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB4-0106EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB4-0107DALIADVKSDYSSDT520
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB4-0107EDALIADVKSDYSSD419
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB4-0108DALIADVKSDYSSDT520
KDM2A-SYNDIG1chr1166999431chr20245654912343DRB4-0108EDALIADVKSDYSSD419

Top

Fusion breakpoint peptide structures of KDM2A-SYNDIG1

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
372ALIADVKSDYSSDTKDM2ASYNDIG1chr1166999431chr20245654912343

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of KDM2A-SYNDIG1

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN372ALIADVKSDYSSDT-5.54906-5.66246
HLA-B14:023BVN372ALIADVKSDYSSDT-4.36183-5.39713
HLA-B52:013W39372ALIADVKSDYSSDT-7.63102-7.74442
HLA-B52:013W39372ALIADVKSDYSSDT-4.45874-5.49404
HLA-A11:014UQ2372ALIADVKSDYSSDT-9.18422-9.29762
HLA-A11:014UQ2372ALIADVKSDYSSDT-8.68857-9.72387
HLA-A24:025HGA372ALIADVKSDYSSDT-8.95466-9.06806
HLA-A24:025HGA372ALIADVKSDYSSDT-5.70785-6.74315
HLA-B27:056PYJ372ALIADVKSDYSSDT-3.47865-4.51395
HLA-B44:053DX8372ALIADVKSDYSSDT-6.77317-6.88657
HLA-B44:053DX8372ALIADVKSDYSSDT-5.34699-6.38229
HLA-A02:016TDR372ALIADVKSDYSSDT-4.69668-4.81008
HLA-A02:016TDR372ALIADVKSDYSSDT-2.18207-3.21737

Top

Vaccine Design for the FusionNeoAntigens of KDM2A-SYNDIG1

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
KDM2A-SYNDIG1chr1166999431chr2024565491616ALIADVKSDYGCTCTCATTGCTGATGTAAAGAGCGACTAC
KDM2A-SYNDIG1chr1166999431chr2024565491716LIADVKSDYCTCATTGCTGATGTAAAGAGCGACTAC

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
KDM2A-SYNDIG1chr1166999431chr2024565491116IEDEDALIADVKSDYATAGAAGATGAAGATGCTCTCATTGCTGATGTAAAGAGCGACTAC
KDM2A-SYNDIG1chr1166999431chr2024565491217EDEDALIADVKSDYSGAAGATGAAGATGCTCTCATTGCTGATGTAAAGAGCGACTACTCA
KDM2A-SYNDIG1chr1166999431chr2024565491318DEDALIADVKSDYSSGATGAAGATGCTCTCATTGCTGATGTAAAGAGCGACTACTCAAGC
KDM2A-SYNDIG1chr1166999431chr2024565491419EDALIADVKSDYSSDGAAGATGCTCTCATTGCTGATGTAAAGAGCGACTACTCAAGCGAC
KDM2A-SYNDIG1chr1166999431chr2024565491520DALIADVKSDYSSDTGATGCTCTCATTGCTGATGTAAAGAGCGACTACTCAAGCGACACA

Top

Information of the samples that have these potential fusion neoantigens of KDM2A-SYNDIG1

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
STADKDM2A-SYNDIG1chr1166999431ENST00000398645chr2024565491ENST00000376862TCGA-BR-6456

Top

Potential target of CAR-T therapy development for KDM2A-SYNDIG1

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note
TgeneSYNDIG1chr11:66999431chr20:24565491ENST0000037686214229_2490259.0IntramembraneHelical
TgeneSYNDIG1chr11:66999431chr20:24565492ENST0000037686214229_2490259.0IntramembraneHelical
TgeneSYNDIG1chr11:66999431chr20:24565491ENST0000037686214182_2020259.0TransmembraneHelical
TgeneSYNDIG1chr11:66999431chr20:24565492ENST0000037686214182_2020259.0TransmembraneHelical

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to KDM2A-SYNDIG1

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to KDM2A-SYNDIG1

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource